Method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes

• US 5,639,630 A
• Filed: 05/16/1995
• Issued: 06/17/1997
• Est. Priority Date: 05/16/1995
• Status: Expired due to Term

• Current Assignee: Siemens Healthcare Diagnostics Incorporated (Siemens AG)
• Original Assignee: Bayer Corporation (Bayer AG)
• Inventors: Cremins, John F., Malin, Michael J., Shapiro, Phyllis
• Primary Examiner(s): Kight, John
• Assistant Examiner(s): LEARY, LOUISE N
• Application Number:
  US08/442,491
• Time in Patent Office: 763 Days
• Field of Search: 435/28, 435/18, 435/15, 435/4, 435/7.24, 435/240.1, 435/240.2, 436/63, 436/74, 436/17, 436/16
• US Class Current: 435/28
• CPC Class Codes: G01N 33/5094 for blood cell populations red blood cells G01N33/80
• CPC Class Codes: Y10T 436/106664 Blood serum or blood plasma standard or control
• CPC Class Codes: Y10T 436/107497 Preparation composition [e.g., lysing or precipitation, etc.]

Abstract

The present invention provides an improved reagent composition and method to perform white blood cell differential counting and subpopulation analysis using both fresh and aged blood samples with accuracy and precision. The invention is particularly applicable for the analysis of aged blood samples that have been stored at room temperature for over a day, thereby allowing accurate and useful information to be obtained from samples that are normally considered to be suboptimal. The improved reagent composition and method are particularly related to the peroxidase method of white blood cell differential determinations. One aspect of the invention includes an improved aqueous reagent composition for carrying out the peroxidase method of differential counting. Another aspect includes the use of a rinse cycle and rinse solution devoid of hemolytic surfactant to alleviate the adverse effects of rinse carryover and to streamline and economize the analytical process, particularly when the analyses are performed on automated hematology analyzers and flow cytometry systems. The composition and method of the invention provide clinically useful data for the differential analysis of whole blood samples.

Claims

1. An improved method for determining a differential white blood cell count and subpopulation analysis on a fresh or aged whole blood sample containing red blood cells and white blood cells, said method based on measuring the intrinsic peroxidase activity of white blood cell subpopulations in said sample, comprising the steps of:

a) mixing said blood sample with an aqueous reagent composition to form a uniform reaction mixture, said reagent composition comprising;

(i) a nonionic polyethoxylate surfactant at a concentration effective to lyse said red blood cells to release hemoglobin, but not to lyse said white blood cell populations in said sample;

(ii) an ionic surfactant of the anionic or zwitterionic class at a concentration effective to lyse said red cells, but not to lyse said white blood cell populations in said sample;

(iii) formaldehyde or paraformaldehyde at a concentration effective to chemically crosslink said white blood cells, but not to crosslink said lysable red blood cells in said sample;

(iv) a sugar or sugar alcohol at a concentration effective to increase the detectability of lymphocytes in said sample; and

(v) a buffer or buffer mixture to maintain a neutral or near-neutral pH of said reaction mixture between about 6.8 to about 8.0;

b) heating said reaction mixture of step a) to a temperature of from about 60°

C. to about 75°

C., whereby said red blood cells in said sample are lysed and said white blood cells are fixed; and

c) staining at least a portion of said white blood cells in said reaction mixture to yield a population of stained white blood cells and a population of unstained white blood cells in suspension;

wherein the presence of both said nonionic surfactant and said ionic surfactant in said aqueous reagent mixture provides accurate and reliable white blood cell differential counting results following step c) for fresh blood samples and for aged blood samples that have been stored at room temperature for at least about a day postdraw.

2. The method according to claim 1, wherein said nonionic surfactant of step a) i) has a hydrophilic lipophilic balance or HLB value of between about 9.3 and about 17.5.

3. The method according to claim 2, wherein said HLB value of said nonionic surfactant is between about 9.5 to about 17.3.

4. The method according to claim 3, wherein said HLB value of said nonionic surfactant is between about 9.7 to about 16.9.

8. The method according to claim 1 or claim 5, wherein said nonionic polyethoxylate surfactant is selected from the group consisting of straight chain aliphatic hydrophobes etherified to polyethylene glycol;

branched chain aliphatic or aromatic octylphenyl hydrophobes etherified to polyethylene glycol;

straight chain aliphatic or aromatic nonylphenyl hydrophobes etherified to polyethylene glycol; and

straight chain aliphatic fatty acids esterified to polyethylene glycol.

9. The method according to claim 8, wherein said nonionic surfactant is a straight chain aliphatic hydrophobe etherified to polyethylene glycol.

10. The method according to claim 9, wherein said nonionic surfactant is Brij®

35.

11. The method according to claim 8, wherein said nonionic surfactant is a branched chain aliphatic or aromatic hydrophobe etherified to polyethylene glycol.

12. The method according to claim 11, wherein said nonionic surfactant is Triton X®

-100.

13. The method according to claim 1 or claim 5, wherein said nonionic polyethoxylate surfactant is present in said aqueous reagent composition of step a) in an amount of about 0.09 g/L to about 0.21 g/L.

14. The method according to claim 1 or claim 5, wherein said ionic surfactant is of said anionic class.

15. The method according to claim 14, wherein said anionic surfactant comprises an alkali metal salt of an alkyl sulfate containing from about 10 to 16 carbon atoms.

16. The method according to claim 15, wherein said anionic surfactant comprises an alkali metal dodecyl sulfate.

17. The method according to claim 16, wherein said anionic surfactant is sodium dodecyl sulfate.

18. The method according to claim 1 or claim 5, wherein said ionic surfactant is of said zwitterionic class.

19. The method according to claim 18, wherein said zwitterionic surfactant is a sulfobetaine.

20. The method according to claim 19, wherein said sulfobetaine is tetradecyldimethylammoniopropanesulfonate or TDAPS.

21. The method according to claim 18, wherein said zwitterionic surfactant is a cholic acid derivative.

22. The method according to claim 21, wherein said cholic acid derivative is 3-[(3-cholamidopropyl)dimethylammonio]-2hydroxy-1-propanesulfonate.

23. The method according to claim 14 or claim 18, wherein said anionic or zwitterionic surfactant is present in the reagent solution of step a) in an amount of about 0.050 g/L to about 0.125 g/L.

24. The method according to claim 1 or claim 5, wherein said aqueous reagent composition of step a) further comprises a chelator of polyvalent metal ions.

25. The method according to claim 24, wherein said polyvalent metal ion chelator is EDTA;

EGTA;

disodium EDTA or EGTA;

trisodium EDTA or EGTA;

or tetrasodium EDTA or EGTA at a concentration of about 1 mM to about 5 mM.

26. The method according to claim 1 or claim 5, wherein said reagent composition of step a) further comprises an alkali metal chloride salt.

27. The method according to claim 26, wherein said alkali metal chloride salt in said reagent composition of step a) is selected from the group consisting of NaCl, KCl, and LiCl.

28. The method according to claim 27, wherein said salt is NaCl present in said reagent composition in an amount of from about 6.8 mM to about 10.3 mM.

29. The method according to claim 1 or claim 5, wherein formaldehyde is present in said reagent composition in a concentration of from about 52 g/L to about 58 g/L.

30. The method according to claim 1 or claim 5, wherein said buffer or buffer mixture maintains the pH of said aqueous reagent composition at between about 7.0 to about 7.4.

31. The method according to claim 1 or claim 5, wherein said buffer comprises a buffer mixture of Na₂ HPO₄ and NaH₂ PO₄.

32. The method according to claim 1 or claim 5, wherein said staining step involves peroxidase staining of peroxidase-active white blood cells.

33. The method according to claim 32, wherein said staining step comprises rapidly mixing said reaction mixture with hydrogen peroxide and a chromogen.

34. The method according to claim 31, wherein said chromogen is 4-chloro-1-napthol.

35. The method according to claim 1 or claim 5, wherein said sugar or sugar alcohol is selected from the group consisting of sucrose, fructose, dextrose, sorbitol, and mannitol.

36. The method according to claim 35, wherein said sugar alcohol is sorbitol.

37. The method according to claim 36, wherein sorbitol is present in said reagent composition of step a) in an amount of from about 110 g/L to about 120 g/L.

38. The method according to claim 1 or claim 5, further comprising the step of passing the suspension of said stained and unstained white blood cells of step c) through an electro-optical detection system and obtaining a differential white blood cell count of said white blood cells in the suspension.

39. The method according to claim 38, wherein said steps are performed in reaction chambers of an automated hematology analyzer.

40. The method according to claim 39, further comprising the step d) of rinsing said chambers of said automated analyzer with an aqueous rinse reagent composition comprising a nonhemolytic nonionic surfactant that is a copolymer of ethylene oxide and propylene oxide, preferably having a molecular weight of about 950 to about 4000 polyoxypropylene and about 10% to 80% polyoxyethylene, after performing steps a) to c) of said differential counting method.

41. The method according to claim 40, wherein said surfactant comprising said rinse composition is a member of the Pluronic class.

42. The method according to claim 41, wherein said Pluronic is Pluronic P105.

43. The method according to claim 40, wherein said rinse composition further comprises one or more of the following components:

an alkali metal chloride salt selected from the group consisting of NaCl, KCl, and LiCl;

an antimicrobial compound selected from the group consisting of Proclin 150, Proclin 300, Germall 115, Dowacil 200, and Bronopol;

an anti-oxidant compound selected from the group consisting of 3,3+-thiodiproprionic acid, 3,3'"'"'-dithioacetic acid, Trolox™

or vitamin E, BHT or 2, 6-di-tert-butyl-4-methylphenol, BHA or 2-tert-butyl-4-methoxyphenol, and MEHQ or ρ

-methoxyphenol; and

a buffer or buffer mixture to maintain the pH of said aqueous rinse composition at about 6.9 to about 7.6.

44. The method according to claim 40, wherein said aqueous rinse composition has an osmolality of between about 285 mOsmol/kg to about 305 mOsmol/kg.

45. The method according to claim 43, wherein said aqueous rinse composition comprises NaCl, Proclin 150, 3,3'"'"'-thiodiproprionic acid, and a buffer or buffer mixture to maintain said pH at about 7.0 to about 7.5.

46. The method according to claim 45, wherein, in said aqueous rinse composition, NaCl is present at a concentration of about 7.40 g/L to 8.0 g/L;

Proclin 150 is present at a concentration of about 0.25 mL/L to 0.60 mL/L; and

3,3'"'"'-thiodiproprionic acid is present at a concentration of about 50 mg/L to 150 mg/L.

79. The method according to claim 1 or claim 5, wherein said buffer or said buffer mixture maintains the pH of said aqueous reagent composition at between about 6.9 to about 7.6.

5. An improved method for determining a differential white blood cell count and subpopulation analysis on a fresh or aged whole blood sample containing red blood cells and white blood cells, said differential counting method based on the measurement of intrinsic peroxidase activity of white blood cell subpopulations in said sample, comprising the steps of:

a) mixing said blood sample with an aqueous reagent composition to form a reaction mixture, said reagent composition comprising;

(i) a nonionic polyethoxylate surfactant having a hydrophilic lipophilic balance or HLB value of between about 9.3 and about 17.5 and present at a concentration effective to lyse said red cells to release hemoglobin, but not to lyse said white blood cell populations in said sample;

(ii) an ionic surfactant of the anionic or zwitterionic class at a concentration effective to lyse said red cells, but not to lyse said white blood cell populations in said sample;

(iii) formaldehyde or paraformaldehyde at a concentration effective to chemically crosslink said white blood cells, but not to crosslink said lysable red blood cells in said sample;

(iv) a sugar or sugar alcohol at a concentration effective to increase the detectability of lymphocytes in said sample; and

(v) a buffer or buffer mixture to maintain the pH of said reagent mixture at a neutral or near-neutral pH of between about 6.8 to about 8.0;

b) heating said reaction mixture prepared in step a) to a temperature of from about 60°

C. to about 75°

C., whereby said red blood cells in said sample are lysed and said whim blood cells are fixed; and

c) staining at least a portion of said white blood cells in said reaction mixture to yield a population of stained white blood cells and a population of unstained white blood cells in suspension;

wherein the presence of both said nonionic surfactant and said ionic surfactant in said aqueous reagent mixture provides accurate and reliable whim blood cell differential counting results following step c) for fresh blood samples and for aged blood samples that have been stored at room temperature for at least about a day postdraw.

6. The method according to claim 5, wherein said HLB value of said nonionic surfactant in step a) i) is between about 9.5 to about 17.3.

7. The method according to claim 6, wherein said HLB value of said nonionic surfactant is between about 9.7 to about 16.9.

47. An improved reagent composition for lysing red blood cells and staining leukocytes for the determination of a leukocyte differential count and subpopulation analysis of a whole blood sample, said differential count based on measuring endogenous peroxidase activity in subpopulations of said leukocytes in said blood sample, which comprises in aqueous admixture:

a) a nonionic polyethoxylate surfactant at a concentration effective to lyse said red cells to release hemoglobin, but not to lyse said white blood cell populations in said sample;

b) an anionic or zwitterionic surfactant at a concentration effective to lyse said red cells to release hemoglobin, but not to lyse said white blood cell populations in said sample;

c) a sugar or sugar alcohol at a concentration effective to increase the detectability of lymphocytes in said sample;

d) formaldehyde or paraformaldehyde at a concentration effective to chemically crosslink said white blood cells, but not to crosslink said lysable red blood cells in said sample; and

e) a buffer or buffer mixture to maintain the pH of said reagent composition at between about 6.8 to about 8.0.

48. The composition according to claim 47, wherein said nonionic surfactant has a hydrophilic lipophilic balance or HLB value of between about 9.3 to about 17.3.

49. The composition according to claim 48, wherein said HLB value of said nonionic surfactant is between about 9.7 to about 16.9.

50. The composition according to claim 47, further comprising a chelator of polyvalent metal ions.

52. The composition according to claim 47 or claim 51, wherein said nonionic polyethoxylate surfactant is selected from the group consisting of straight chain aliphatic hydrophobes etherified to polyethylene glycol;

branched chain aliphatic or aromatic octylphenyl hydrophobes etherified to polyethylene glycol;

straight chain aliphatic or aromatic nonylphenyl hydrophobes etherified to polyethylene glycol; and

straight chain aliphatic fatty acids esterified to polyethylene glycol.

53. The composition according to claim 52, wherein said nonionic surfactant is a straight chain aliphatic hydrophobe etherified to polyethylene glycol.

55. The composition according to claim 52, wherein said nonionic surfactant is a branched chain aliphatic or aromatic hydrophobe etherified to polyethylene glycol.

56. The composition according to claim 55, wherein said nonionic surfactant is Triton X®

-100.

57. The composition according to claim 47 or claim 51, wherein said nonionic surfactant is present in said composition in an amount of from about 0.09 g/L to about 0.20 g/L.

58. The composition according to claim 47 or claim 51, wherein said surfactant is an anionic surfactant.

59. The composition according to claim 58, wherein said anionic surfactant comprises an alkali metal salt of an alkyl sulfate containing from about 10 to 16 carbon atoms.

60. The composition according to claim 59, wherein said anionic surfactant comprises an alkali metal dodecyl sulfate.

61. The composition according to claim 60, wherein said anionic surfactant is sodium dodecyl sulfate.

62. The composition according to claim 47 or claim 51, wherein said surfactant is a zwitterionic surfactant.

63. The composition according to claim 62, wherein said zwitterionic surfactant is a sulfobetaine.

64. The composition according to claim 63, wherein said sulfobetaine is tetradecyldimethylammoniopropanesulfonate or TDAPS.

65. The composition according to claim 62, wherein said zwitterionic surfactant is a cholic acid derivative.

66. The composition according to claim 65, wherein said cholic acid derivative is 3-[(3-cholamidopropyl)dimethylammonio]-2hydroxy-1-propanesulfonate.

67. The composition according to claim 47 or claim 51, wherein said anionic or zwitterionic surfactant is present in the composition in an amount of about 0.050 g/L to about 0.125 g/L.

68. The composition according to claim 47 or claim 51, further comprising an alkali metal chloride salt.

69. The composition according to claim 68, wherein said alkali metal chloride salt is selected from the group consisting of NaCl, KCl, and LiCl.

70. The composition according to claim 69, wherein said salt is NaCl and is present in said reagent composition at a concentration of from about 6.8 mM to about 10.3 mM.

71. The composition according to claim 47 or claim 51, wherein formaldehyde is present in said composition in a concentration of from about 52 g/L to about 58 g/L.

72. The composition according to claim 48 or claim 51, wherein said buffer comprises a mixture of Na₂ HPO₄ and NaH₂ PO₄.

73. The composition according to claim 47 or claim 51, wherein said sugar or sugar alcohol is selected from the group consisting of sucrose, fructose, dextrose, sorbitol, and mannitol.

74. The composition according to claim 73, wherein said sugar alcohol is sorbitol.

75. The composition according to claim 74, wherein sorbitol is present in said composition at a concentration of from about 110 g/L to about 120 g/L.

76. The composition according to claim 47 or claim 51, further comprising a chelator of polyvalent metal ions.

77. The composition according to claim 76, wherein said polyvalent metal ion chelator is EDTA;

EGTA;

disodium EDTA or EGTA;

trisodium EDTA or EGTA;

or tetrasodium EDTA or EGTA.

78. The composition according to claim 77, wherein said chelator is disodium EDTA and is present at a concentration of about 1 mM to about 5 mM.

80. The reagent composition according to claim 47 or claim 51, wherein said buffer or said buffer mixture maintains the pH of said aqueous reagent composition at between about 6.9 to about 7.6.

51. An improved reagent composition for lysing red blood cells and staining leukocytes for the determination of a differential leukocyte count and subpopulation analysis of a whole blood sample based on the measurement of endogenous peroxidase activity in subpopulations of said leukocytes in said blood sample, which comprises in aqueous admixture:

a) a nonionic polyethoxylate surfactant having a hydrophilic lipophilic balance or HLB value of between about 9.3 and about 17.5 and at a concentration effective to lyse said red cells to release hemoglobin, but not to lyse said white blood cell populations in said sample;

b) an anionic or zwitterionic surfactant at a concentration effective to lyse said red cells to release hemoglobin, but not to lyse said white blood cell populations in said sample;

c) a sugar or sugar alcohol at a concentration effective to increase the detectability of lymphocytes in said sample;

d) formaldehyde or paraformaldehyde at a concentration effective to chemically crosslink said white blood cells, but not to crosslink said lysable red blood cells in said sample; and

e) a buffer or buffer mixture to maintain the pH of said reagent composition at between about 6.8 to about 8.0.

54. The composition according to claim 51, wherein said nonionic surfactant is Brij®

35.